PolyPid (PYPD) Research & Development (2019 - 2026)

PolyPid has disclosed Research & Development across 8 years of filings, most recently posting $6.1 million for Q2 2026.

• In Q2 2026, Research & Development fell 1.45% year-over-year to $6.1 million; the TTM figure through Jun 2026 stood at $23.4 million (down 7.8% YoY), while the FY2025 annual figure was $23.8 million, up 4.37% from the prior year.
• Research & Development came in at $6.1 million for Q2 2026 at PolyPid, up from $5.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $8.7 million in Q1 2022 to a low of $3.8 million in Q1 2023.
• Average Research & Development over 5 years is $5.7 million, with a median of $5.9 million recorded in 2024.
• Year-over-year, Research & Development sank 56.38% in 2023 and jumped 56.96% in 2024.
• Over 5 years, Research & Development stood at $4.7 million in 2022, then slipped by 1.44% to $4.6 million in 2023, then soared by 53.16% to $7.0 million in 2024, then declined by 11.51% to $6.2 million in 2025, then fell by 1.5% to $6.1 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $6.1 million in Q2 2026, $5.8 million in Q1 2026, and $6.2 million in Q4 2025.